Collegium to Participate in Upcoming Investor Conferences

STOUGHTON, Mass., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that management will participate in the following investor conferences in September:

• The Janney Healthcare Conference 2019 on Monday, September 9th in New York City. Management will present at 8:15 a.m. ET and will also participate in investor meetings.  
• The H.C. Wainwright 21st Annual Global Investment Conference on Tuesday, September 10th in New York City. Management will present at 11:15 a.m. ET and will also participate in investor meetings.

About Collegium Pharmaceutical, Inc.

Collegium is a specialty pharmaceutical company committed to being the leader in responsible pain management. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the company’s website at www.collegiumpharma.com.

Contact: Alex Dasalla [email protected]

Source: Collegium Pharmaceutical, Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Biofrontera Inc. Reports Strong Second Quarter 2026 Financial Results Driven by 33% Revenue Growth
• Correction: Notification regarding Interest Rates for the period
• Kinetic Technologies Introduces KTS1642Q Automotive Load Switches Designed to Simplify Compliance with ISO 16750-2 and ISO 7637-2 Power Transient Standards